keyword
MENU ▼
Read by QxMD icon Read
search

iRGD

keyword
https://www.readbyqxmd.com/read/29903055/irgd-mediated-and-enzyme-induced-precise-targeting-and-retention-of-gold-nanoparticles-for-the-enhanced-imaging-and-treatment-of-breast-cancer
#1
Yuanyuan Yang, Qiling Chen, Siyu Li, Wen Ma, Guangyu Yao, Fei Ren, Zheng Cai, Peng Zhao, Guochao Liao, Jingyuan Xiong, Zhiqiang Yu
Despite the great achievements of nanomedicines made in cancer chemotherapy, precise tumor targeting and deep penetration are still major challenges. Many nanomedicines can only passively accumulate near leaky site of tumor vessels through the enhanced permeability and retention (EPR) effect and cannot reach the deep region of tumor. To improve the tumor targeting, penetration and retention efficiency, an iRGD-mediated and enzyme-induced precise targeting gold nanoparticles system (iRGD/AuNPs-A&C) was developed by simply coadministering a tumor-homing penetration peptide iRGD (CRGDKGPDC) with a legumain responsive aggregable gold nanoparticle (AuNPs-A&C)...
August 1, 2018: Journal of Biomedical Nanotechnology
https://www.readbyqxmd.com/read/29903054/ultrasound-triggered-drug-delivery-for-breast-tumor-therapy-through-irgd-targeted-paclitaxel-loaded-liposome-microbubble-complexes
#2
Jing Zhang, Song Wang, Zhiting Deng, Li Li, Guanghong Tan, Xin Liu, Hairong Zheng, Fei Yan
Liposome-microbubble complexes (LMC) have become a promising therapeutic carrier for ultrasound-triggered local drug release. However, it is still desirable for the released drugs to be delivered to tumors as effectively as possible. Here, we fabricated iRGD-targeted paclitaxel-loaded liposome-microbubble complexes (iRGD-PTX-LMC) and investigated the feasibility of enhancing the local drug delivery to breast tumors by using these complexes along with ultrasound irradiation. Our results showed that iRGD-modified PTX-loaded liposomes (iRGD-PTX-PL) were successfully conjugated to the surface of microbubbles (MBs) through biotin-avidin linkage...
August 1, 2018: Journal of Biomedical Nanotechnology
https://www.readbyqxmd.com/read/29888319/evidence-of-anti-tumoral-efficacy-in-an-immune-competent-setting-with-an-irgd-modified-hyaluronidase-armed-oncolytic-adenovirus
#3
Ahmed Abdullah Al-Zaher, Rafael Moreno, Carlos Alberto Fajardo, Marcel Arias-Badia, Martí Farrera, Jana de Sostoa, Luis Alfonso Rojas, Ramon Alemany
To enhance adenovirus-mediated oncolysis, different approaches that tackle the selectivity, tumor penetration, and spreading potential of oncolytic adenoviruses have been reported. We have previously demonstrated that insertion of the internalizing Arginine-Glycine-Aspartic (iRGD) tumor-penetrating peptide at the C terminus of the fiber or transgenic expression of a secreted hyaluronidase can improve virus tumor targeting and spreading. Here we report a new oncolytic adenovirus ICOVIR17K-iRGD in which both modifications have been incorporated...
March 30, 2018: Molecular Therapy Oncolytics
https://www.readbyqxmd.com/read/29878758/coadministration-of-irgd-with-multistage-responsive-nanoparticles-enhanced-tumor-targeting-and-penetration-abilities-for-breast-cancer-therapy
#4
Chuan Hu, Xiaotong Yang, Rui Liu, Shaobo Ruan, Yang Zhou, Wei Xiao, Wenqi Yu, Chuanyao Yang, Huile Gao
Limited tumor targeting and poor penetration of nanoparticles are two major obstacles to improving the outcome of tumor therapy. Herein, coadministration of tumor-homing peptide iRGD and multistage-responsive penetrating nanoparticles for the treatment of breast cancer are reported. This multistage-responsive nanoparticle, IDDHN, was comprised of NO donor-modified hyaluronic acid shell (HN) and small-sized dendrimer, namely Dendri-Graft-L-Lysine conjugated with doxorubicin and indocyanine (IDD). The results showed that IDDHN could be degraded rapidly from about 330 nm to a smaller size that was in a size range of 35 nm to 150 nm (most at 35~60 nm) after hyaluronidase (HAase) incubation for 4 hours, in vitro cellular uptake demonstrated that iRGD could mediate more endocytosis of IDDHN into 4T1 cells, which was attributed to the overexpression of αvβ3 integrin receptor...
June 7, 2018: ACS Applied Materials & Interfaces
https://www.readbyqxmd.com/read/29799599/irgd-decorated-reduction-responsive-nanoclusters-for-targeted-drug-delivery
#5
Hang Hu, Jiangling Wan, Xuetao Huang, Yuxiang Tang, Chen Xiao, Huibi Xu, Xiangliang Yang, Zifu Li
Herein, reduction-responsive disintegratable nanoclusters (NCs) were prepared as a novel nanovehicle for targeted drug delivery. The NCs, with a diameter of ∼170 nm, were self-assembled from hydrophobically modified and iRGD decorated hydroxyethyl starch (iRGD-HES-SS-C18). DOX was loaded into the NCs as a model drug. DOX@iRGD-HES-SS-C18 NCs can disintegrate into smaller ones and release DOX under reduction stimuli. Due to the ligand-receptor binding interactions between iRGD and integrin αV, DOX@iRGD-HES-SS-C18 NCs can specifically bind to the cell membranes of HepG-2 and 4T1 cells (integrin αV positive), resulting in enhanced cellular uptake as compared to DOX@HES-SS-C18 NCs...
May 25, 2018: Nanoscale
https://www.readbyqxmd.com/read/29771149/preparation-and-evaluation-of-tumour-microenvironment-response-multistage-nanoparticles-for-epirubicin-delivery-and-deep-tumour-penetration
#6
Jialing Dai, Shangcong Han, Fang Ju, Mei Han, Lisa Xu, Ruoyu Zhang, Yong Sun
Poor tumour penetration became a major challenge for the use of nanoparticles in anticancer therapy. To further enhance the tumour penetration efficiency, we developed a tumour-microenvironment-responsive multistage drug delivery system which was formed layer by layer via electrostatic interaction with cationic drug-loaded nanoparticles, hyaluronidase (HAase) and iRGD-modified gelatin (G-iRGD). The drug-loaded nanoparticles were formed by self-assembling mPEG-PDPA-PG and encapsulation with epirubicin (EPI)...
May 17, 2018: Artificial Cells, Nanomedicine, and Biotechnology
https://www.readbyqxmd.com/read/29760047/nanoparticles-that-reshape-the-tumor-milieu-create-a-therapeutic-window-for-effective-t-cell-therapy-in-solid-malignancies
#7
Fan Zhang, Sirkka B Stephan, Chibawanye I Ene, Tyrel T Smith, Eric C Holland, Matthias T Stephan
A major obstacle to the success rate of chimeric antigen receptor (CAR-) T cell therapy against solid tumors is the microenvironment antagonistic to T cells that solid tumors create. Conventional checkpoint blockade can silence lymphocyte anti-survival pathways activated by tumors, but because they are systemic, these treatments disrupt immune homeostasis and induce autoimmune side effects. Thus, new technologies are required to remodel the tumor milieu without causing systemic toxicities. Here we demonstrate that targeted nanocarriers that deliver a combination of immune-modulatory agents can remove pro-tumor cell populations and simultaneously stimulate anti-tumor effector cells...
May 14, 2018: Cancer Research
https://www.readbyqxmd.com/read/29722179/co-administration-of-kla-tat-peptide-and-irgd-to-enhance-the-permeability-on-a549-3d-multiple-sphere-cells-and-accumulation-on-xenograft-mice
#8
Cuihua Hu, Xiaolong Chen, Yibing Huang, Yuxin Chen
To enhance the anticancer activity, tumor penetration ability of the hybrid anticancer peptide, in this study, a TAT (RKKRRQRRR) peptide modified kla peptide (KLAKLAKKLAKLAK, with all D-amino acids), named kla-TAT, was co-administrated with the homing/penetrating peptide iRGD which could enhance the permeability of chemical drug in solid tumor and tumor vessel by co-administration. In this study, the non-small cell lung cancer (NSCLC) A549 cell line with the iRGD targeting receptor neuropilin-1 (NRP-1) high expression was selected to establish the 2D monolayer cell, 3D multiple cell spheroids and xenograft mice model...
May 2, 2018: Chemical Biology & Drug Design
https://www.readbyqxmd.com/read/29717725/a-triple-modality-bsa-coated-dendritic-nanoplatform-for-nir-imaging-enhanced-tumor-penetration-and-anticancer-therapy
#9
Jie Cao, Ruifen Ge, Min Zhang, Junfei Xia, Shangcong Han, Wei Lu, Yan Liang, Tingting Zhang, Yong Sun
Functional theranostic systems for drug delivery capable of concurrent near-infrared (NIR) fluorescence imaging, active tumor targeting and anticancer therapies are desired for concise cancer diagnosis and treatment. Dendrimers with controllable size and surface functionalities are good candidates for such platforms. However, integration of active targeting ligands and imaging agents separately on the surface or encapsulation of the imaging agents in the inner core of the dendrimers will result in a more complex composition or reduced drug loading efficiency...
May 2, 2018: Nanoscale
https://www.readbyqxmd.com/read/29615837/synovitis-in-mice-with-inflammatory-arthritis-monitored-with-quantitative-analysis-of-dynamic-contrast-enhanced-nir-fluorescence-imaging-using-irgd-targeted-liposomes-as-fluorescence-probes
#10
Hao Wu, Haohan Wu, Yanni He, Zhen Gan, Zhili Xu, Meijun Zhou, Sai Liu, Hongmei Liu
Background: Rheumatoid arthritis (RA) is a common inflammatory disorder characterized primarily by synovitis and pannus formation in multiple joints, causing joints destruction and irreversible disability in most cases. Early diagnosis and effective therapy monitoring of RA are of importance for achieving the favorable prognosis. Methods: We first prepared the targeted fluorescence probes, and then explored the feasibility of near-infrared (NIR) fluorescence molecular imaging to detect and evaluate the RA via the targeted fluorescence probes by quantitative analysis in this study...
2018: International Journal of Nanomedicine
https://www.readbyqxmd.com/read/29416923/bispecific-tumor-penetrating-protein-anti-egfr-irgd-efficiently-enhances-the-infiltration-of-lymphocytes-in-gastric-cancer
#11
Anqing Zhu, Huizi Sha, Shu Su, Fangjun Chen, Jia Wei, Fanyan Meng, Yang Yang, Juan Du, Jie Shao, Fuzhi Ji, Chong Zhou, Zhengyun Zou, Xiaoping Qian, Baorui Liu
Efficient trafficking of lymphocytes to the tumor microenvironment is crucial for the success of an effective antitumor immunotherapy. A major challenge to achieve effective adoptive immunotherapy is poor tumor penetration and inefficient migration of T cells to the tumor site. Several approaches to facilitate the trafficking of lymphocytes to the tumor microenvironment have been suggested to overcome these obstacles. Here, we address this issue with a focus on the tumor-penetrating peptide iRGD, which can specifically increase the permeability of the tumor vasculature and tumor tissue, enhancing drug penetration...
2018: American Journal of Cancer Research
https://www.readbyqxmd.com/read/29396568/co-administration-of-irgd-with-peptide-hprp-a1-to-improve-anticancer-activity-and-membrane-penetrability
#12
Cuihua Hu, Xiaolong Chen, Yibing Huang, Yuxin Chen
To improve the specificity and penetration of anticancer peptides against tumors, in this study, we examined the effects of co-administration of the membrane-active peptide HPRP-A1 and the tumor homing/penetrating peptide iRGD. iRGD peptide is widely recognized as an efficient cell membrane penetration peptide targeting to αv β3 integrins and neuropilin-1 (NRP-1) receptors, which show high expression in many tumor cells. The anticancer activity, cancer specificity and penetration activity in vitro and in vivo of the co-administered peptides were examined on 2D monolayer cells, 3D multi-cellular spheroids (MCS) and xenograft nude mice...
February 2, 2018: Scientific Reports
https://www.readbyqxmd.com/read/29320614/deep-tumor-penetrating-bioparticulates-inspired-burst-intracellular-drug-release-for-precision-chemo-phototherapy
#13
Ruoning Wang, Yue Han, Bo Sun, Ziqiang Zhao, Yaw Opoku-Damoah, Hao Cheng, Huaqing Zhang, Jianping Zhou, Yang Ding
The relevance of personalized medicine has inspired research for individually concerted diagnosis and therapy. Numerous efforts are devoted to designing drug particulates with capabilities of tumor penetrating and subcellular trafficking to concurrently discharge theranostics in response to multistimulations. In this study, a bioinspired particulate, formulated with whole components of native high-density lipoproteins (HDLs) and decorated with the tumor-penetrating peptide iRGD, is proposed to promote tumor penetration of HDLs (pHDLs) together with payloads...
March 2018: Small
https://www.readbyqxmd.com/read/29304437/peptide-targeted-stimuli-responsive-polymersomes-for-delivering-a-cancer-stemness-inhibitor-to-cancer-stem-cell-microtumors
#14
Fataneh Karandish, James Froberg, Pawel Borowicz, John C Wilkinson, Yongki Choi, Sanku Mallik
Often cancer relapses after an initial response to chemotherapy because of the tumor's heterogeneity and the presence of progenitor stem cells, which can renew. To overcome drug resistance, metastasis, and relapse in cancer, a promising approach is the inhibition of cancer stemness. In this study, the expression of the neuropilin-1 receptor in both pancreatic and prostate cancer stem cells was identified and targeted with a stimuli-responsive, polymeric nanocarrier to deliver a stemness inhibitor (napabucasin) to cancer stem cells...
March 1, 2018: Colloids and Surfaces. B, Biointerfaces
https://www.readbyqxmd.com/read/29107217/ultrasensitive-mri-detection-of-spontaneous-pancreatic-tumors-with-nanocage-based-targeted-contrast-agent
#15
Takahito Kawano, Masaharu Murata, Jeong-Hun Kang, Jing Shu Piao, Sayoko Narahara, Fuminori Hyodo, Nobuhito Hamano, Jie Guo, Susumu Oguri, Kenoki Ohuchida, Makoto Hashizume
Contrast agents with greater specificity and sensitivity are required for the diagnosis of pancreatic cancers by magnetic resonance imaging (MRI). In this study, small heat shock protein 16.5 (Hsp16.5)-based nanocages conjugated to gadolinium(III)-chelated contrast agents and iRGD peptides (which target neuropilin-1 expressed on pancreatic cancer cells) were developed. To investigate whether template size influences relaxivity, nanocages with one to four hydrophobic domains were designed. MRI data showed that larger nanocages had higher T1 relaxivity than smaller nanocages, which resulted from a reduction in molecular tumbling rates caused by an increase in nanocage size, and a robust cage structure resulting from the introduction of hydrophobic domains...
October 20, 2017: Biomaterials
https://www.readbyqxmd.com/read/29070455/-efficacy-of-internalized-rgd-modified-echogenic-liposomes-in-diagnosis-and-treatment-in-a-mouse-model-of-rheumatoid-arthritis
#16
Zhen Gan, Hao Wu, Hao-Han Wu, Mei-Jun Zhou, Fei Yan, Hong-Mei Liu
OBJECTIVE: To prepare internalized RGD (iRGD) modified echogenic liposomes containing methotrexate (MTX) and indocyanine green (ICG) (iRGD MTX ICG ELIP) and evaluate its targeting efficiency and inhibitory effect combined with ultrasound on synovial cells. METHODS: iRGD MTX ICG ELIP was prepared by the thin film rehydration and freeze-lyophilization method and its general characteristics and acoustic responsiveness were assessed. The targeting effect of the prepared liposome was observed by assessing its cell uptake in vitro...
October 20, 2017: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://www.readbyqxmd.com/read/29018206/tumor-penetrating-delivery-of-sirna-against-tnf%C3%AE-to-human-vestibular-schwannomas
#17
Yin Ren, Jessica E Sagers, Lukas D Landegger, Sangeeta N Bhatia, Konstantina M Stankovic
Vestibular schwannoma (VS) is the most common tumor of the cerebellopontine angle, and it typically presents with sensorineural hearing loss. The genomic landscape of schwannoma is complex and many of the molecules implicated in VS pathogenesis represent targets not amenable to antibody-based or small molecule therapeutics. Tumor-targeted delivery of small interfering RNA (siRNA) therapeutics provides a direct and effective means to interrogate targets while minimizing off-target effects. To establish a preclinical model for therapeutic inhibition of putative targets in VS, archived tumor specimens, fresh tumor cells derived from patients with sporadic VS, and an established schwannoma cell line were screened...
October 10, 2017: Scientific Reports
https://www.readbyqxmd.com/read/28989666/development-of-a-high-quantum-yield-dye-for-tumour-imaging
#18
Dan Yang, Huasen Wang, Chengjie Sun, Hui Zhao, Kuan Hu, Weirong Qin, Rui Ma, Feng Yin, Xuan Qin, Qianling Zhang, Yongye Liang, Zigang Li
A fluorescent dye, FEB, with high fluorescence quantum yield for tumour imaging is reported. FEB dyes can be efficiently synthesized in three steps and then easily modified with either PEG or PEG-iRGD to yield FEB-2000 or FEB-2000-iRGD, respectively. Both modified dyes showed negligible toxicity and were thus able to be adopted for in vivo tumour imaging. PEG modification endowed the dye FEB-2000 with both long circulating times and good tumour targeting properties in a MDA-MB-231 xenograft model. Further conjugation with iRGD to generate FEB-2000-iRGD showed minimal targeting enhancement...
September 1, 2017: Chemical Science
https://www.readbyqxmd.com/read/28923749/irgd-decorated-red-shift-emissive-carbon-nanodots-for-tumor-targeting-fluorescence-imaging
#19
Yuanyuan Yang, Xuefeng Wang, Guochao Liao, Xiqiang Liu, Qiling Chen, Hongmei Li, Ling Lu, Peng Zhao, Zhiqiang Yu
Carbon nanodots (CDs) have been exhibiting increasing applications owing to their luminescence properties and biocompatibility as imaging probes in diagnosis. However, poor tumor targeting and penetration of CDs is still the biggest challenge limiting their tumor imaging efficacy. To improve the tumor targeting and penetration efficiency of CDs, we developed an active tumor targeting imaging system by simply fabricating a tumor-homing penetration peptide iRGD (CRGDKGPDC) to red shift emissive CDs (iRGD-CDs) with a physical method...
September 6, 2017: Journal of Colloid and Interface Science
https://www.readbyqxmd.com/read/28868347/major-effect-of-transcytosis-on-nano-drug-delivery-to-pancreatic-cancer
#20
Xiangsheng Liu, Jinhong Jiang, Andre E Nel, Huan Meng
We demonstrated that activated transcytosis is a major mechanism to complement the classic enhanced permeability and retention effect in pancreatic cancer. This was achieved by using an iRGD peptide that triggers transcytosis pathway at the tumor site. Co-administration of unconjugated iRGD substantially improved the effect of the chemotherapeutics delivering nanocarrier, and resulted in survival improvement in mice. Since the iRGD effect is commensurate with neuropilin-1 expression on tumor vasculature, it is necessary to contemplate a personalized approach to implement this technology...
2017: Molecular & Cellular Oncology
keyword
keyword
76742
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"